A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

Status:
Withdrawn

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

This clinical trial is a Phase 2 study of a single subcutaneous injection of TAK-850 for 22 days in healthy Japanese adults.

Phase 2

Takeda